Prenylamine

CHEMBL24072 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

329.5 g/mol

LogP

6.0

Phase

4

Prenylamine is a calcium channel antagonist and monoamine depleting agent that was used for the treatment of angina pectoris by reducing myocardial oxygen demand through vasodilation and negative inotropic effects. It was withdrawn from many markets due to its propensity to cause QT prolongation and potentially fatal ventricular arrhythmias, particularly torsades de pointes.

Moleküler Ağırlık

329,5000 g/mol

LogP

6,00

TPSA

12,00 Å²

Lipinski RO5

Geçer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

CC(Cc1ccccc1)NCCC(c1ccccc1)c1ccccc1

InChI

InChI=1S/C24H27N/c1-20(19-21-11-5-2-6-12-21)25-18-17-24(22-13-7-3-8-14-22)23-15-9-4-10-16-23/h2-16,20,24-25H,17-19H2,1H3

Molecular Formula

C24H27N

HBD / HBA

1 / 1

Döndürülebilir Bağlar

8

Ağır Atomlar

25

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

Prenylamine is a calcium channel antagonist and monoamine depleting agent that was used for the treatment of angina pectoris by reducing myocardial oxygen demand through vasodilation and negative inotropic effects. It was withdrawn from many markets due to its propensity to cause QT prolongation and potentially fatal ventricular arrhythmias, particularly torsades de pointes.

Yes, Prenylamine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL24072. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 9801. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Prenylamine PillFYI'da

Yapı

Hızlı Veriler

Formül: C24H27N

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.